Predictive value of co-existing genetic alterations and tumor mutation burden for patients with completely resected non-small cell lung cancer harboring EGFR mutation: Biomarker analysis of phase III IMPACT study

被引：0
|
作者：
Ikeda, Satoshi
Tsuboi, Masahiro
Sakai, Kazuko
Misumi, Toshihiro
Akamatsu, Hiroaki
Iwamoto, Yasuo
Sakakura, Noriaki
Nakamura, Atsushi
Ohde, Yasuhisa
Hayashi, Hidetoshi
Okishio, Kyoichi
Okada, Morihito
Yoshino, Ichiro
Okami, Jiro
Takahashi, Kazuhisa
Ikeda, Norihiko
Mitsudomi, Tetsuya
Tada, Hirohito
Nakagawa, Kazuhiko
Nishio, Kazuto
机构：
[1] Kanagawa Cardiovasc & Resp Ctr, Yokohama, Kanagawa, Japan
[2] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[3] Kindai Univ, Fac Med, Osakasayama, Japan
[4] Natl Canc Ctr Hosp East, Dept Data Sci, Kashiwa, Chiba, Japan
[5] Wakayama Med Univ, Internal Med 3, Wakayama, Japan
[6] Hiroshima Citizens Hosp, Hiroshima, Japan
[7] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[8] Sendai Kousei Hosp, Sendai, Miyagi, Japan
[9] Shizuoka Canc Ctr, Shizuoka, Sunto Gun, Japan
[10] Natl Hosp Org Kinki Chuo Chest Med Ctr, Sakai, Osaka, Japan
[11] Hiroshima Univ, Hiroshima, Japan
[12] Chiba Univ, Grad Sch Med, Chiba, Japan
[13] Osaka Int Canc Inst, Osaka, Japan
[14] Juntendo Univ, Div Resp Med, Fac Med, Tokyo, Japan
[15] Grad Sch Med, Tokyo, Japan
[16] Tokyo Med Univ, Tokyo, Japan
[17] Suita Tokushukai Hosp, Suita, Osaka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8524
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Prognostic and predictive effects of KRAS mutation subtype in completely resected non-small cell lung cancer (NSCLC): A LACE-bio study
    Shepherd, Frances A.
    Bourredjem, Abderrahmane
    Brambilla, Elisabeth
    Domerg, Caroline
    Douillard, Jean-Yves
    Filipits, Martin
    Graziano, Stephen L.
    Hainaut, Pierre
    Janne, Pasi Antero
    Le Chevalier, Thierry
    Le Teuff, Gwenael
    Pignon, Jean-Pierre
    Pirker, Robert
    Seymour, Lesley
    Soria, Jean-Charles
    Taron, Miquel
    Tsao, Ming Sound
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [32] Impact of Inflammatory Markers and Body Mass Index on TKI Toxicity in Patients With Non-Small Cell Lung Cancer Harboring an EGFR Mutation
    Runciman, T.
    Carracedo, C.
    Motta, R.
    Aliaga, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S590 - S591
  • [33] The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations
    Akihiro Yoshimura
    Tadaaki Yamada
    Naoko Okura
    Takayuki Takeda
    Wataru Furutani
    Yutaka Kubota
    Shinsuke Shiotsu
    Osamu Hiranuma
    Naoya Nishioka
    Yusuke Chihara
    Nobuyo Tamiya
    Yoshiko Kaneko
    Junji Uchino
    Koichi Takayama
    BMC Cancer, 18
  • [34] The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations
    Yoshimura, Akihiro
    Yamada, Tadaaki
    Okura, Naoko
    Takeda, Takayuki
    Furutani, Wataru
    Kubota, Yutaka
    Shiotsu, Shinsuke
    Hiranuma, Osamu
    Nishioka, Naoya
    Chihara, Yusuke
    Tamiya, Nobuyo
    Kaneko, Yoshiko
    Uchino, Junji
    Takayama, Koichi
    BMC CANCER, 2018, 18
  • [35] Analysis of the EGFR gene mutation in patients with non-small cell lung cancer in a Chinese population
    Li, Ju-yi
    Liu, Ying
    Deng, Ai-ping
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 15 (08) : 1637 - 1641
  • [36] PD-L1 Expression as a Predictive Biomarker in Advanced Non-Small Cell Lung Cancer Patients with or without EGFR Mutation
    Siripoon, T.
    Incharoen, P.
    Trachu, N.
    Munthum, D.
    Kamprerasart, K.
    Reungwetwattana, T.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S699 - S700
  • [37] Phase II study of carboplatin and pemetrexed followed by gefitinib for patients with advanced non-small cell lung cancer harboring sensitive EGFR mutation.
    Manabe, Saki
    Oshita, Fumihiro
    Murakami, Shuji
    Kondo, Tetsuro
    Saito, Haruhiro
    Kaneko, Takeshi
    Yamada, Kouzo
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] Clinical Effects of Icotinib for Brain Metastasis in Chinese Non-Small Cell Lung Cancer Patients Harboring an EGFR Mutation
    Hou, Helei
    Xu, Xiaomei
    Wang, Xiaofei
    Deng, Lihua
    Tan, Airong
    Liu, Congmin
    Yu, Wenjun
    Zhang, Chuantao
    Yan, Chun
    Cheng, Xiaofeng
    Zhang, Xiaochun
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S644 - S644
  • [39] A Phase III Study of Adjuvant Chemotherapy in Patients with Completely Resected, Node-Negative Non-Small Cell Lung Cancer
    Kunitoh, H.
    Sakurai, H.
    Tsuboi, M.
    Wakabayashi, M.
    Okada, M.
    Suzuki, K.
    Ikeda, N.
    Takahama, M.
    Takenoyama, M.
    Ohde, Y.
    Yoshiya, K.
    Matsumoto, I.
    Yamashita, M.
    Marutsuka, T.
    Date, H.
    Hasumi, T.
    Yamashita, Y.
    Okumura, N.
    Watanabe, S.
    Asamura, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S270 - S271
  • [40] A study of EGFR wild-type non-small cell lung cancer ALK genetic mutation
    Wang, Shoufeng
    Mao, Naiquan
    Zuo, Chuantian
    Pan, Hong
    Xie, Tong
    Huang, Yaoyuan
    Pan, Qi
    Wu, Junwei
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (05) : 976 - 980
12345